Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Bayer & Monsanto v. Hodel: Roundup Ready Soybean Patent Win | PatSnap
Explore in Eureka
Case ID4:23-cv-00084
FiledJan 2023
ClosedDec 2024
Patent Litigation

Bayer & Monsanto v. Hodel: $603,965 Summary Judgment for Biotech Seed Patent Infringement

Bayer AG and Monsanto Technology LLC secured summary judgment against Missouri farmer Michael J. Hodel for infringing two biotech soybean patents — covering Xtend/MON89788 soybean technology and dicamba-tolerant crop systems — and for breaching Technology Stewardship Agreements across three consecutive growing seasons. The court awarded $603,965 in liquidated damages and entered a permanent injunction barring further unauthorized use.

Resolution time
693days
693 days from filing to judgment — consistent with contested patent enforcement timelines in the Eastern District of Missouri
Patents asserted
2
US7838729B2 and US9944945B2 — chloroplast transit peptides (DMO targeting) and soybean event MON89788 detection
Outcome
Judgment on the merits for Plaintiff
Summary judgment on merits — liability, liquidated damages, and permanent injunction all entered for plaintiffs
Cost ruling
Judgment Entered
$603,965 in liquidated damages awarded; permanent injunction against further seed infringement and dicamba misuse
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Seed biotech enforcement: summary judgment on patents and contract breach

Filed on 25 January 2023 in the Eastern District of Missouri before Judge John A. Ross, this case pitted agricultural biotechnology giants Bayer AG and Monsanto Technology LLC against individual farmer Michael J. Hodel. The plaintiffs asserted infringement of two core biotech seed patents — US7838729B2, covering soybean event MON89788 and its detection methods, and US9944945B2, covering chloroplast transit peptides for DMO targeting used in dicamba-tolerant Xtend soybean systems — alongside breach of Technology Stewardship Agreements (TSAs) for the 2020, 2021, and 2022 growing seasons.

The case closed on 18 December 2024 via summary judgment in favour of the plaintiffs — a plaintiff-favourable resolution on the merits without trial. Judge Ross found Hodel liable for patent infringement and TSA breach, entering judgment of $603,965 in liquidated damages and issuing a permanent injunction prohibiting Hodel from making, using, saving, planting, selling, or transferring any seed containing plaintiffs’ patented biotechnologies without express written permission, and from applying unapproved dicamba formulations to Xtend crops.

The 693-day duration is consistent with contested district court proceedings, though the resolution by summary judgment — rather than trial — suggests plaintiffs were able to establish liability on undisputed material facts, likely supported by seed sampling data and TSA documentary evidence. The liquidated damages figure reflects contractual penalty provisions in the TSAs for three seasons. What remains unknown from the public record is whether Hodel disputed the technical infringement findings or primarily contested damages quantification.

Case at a glance
Case no.4:23-cv-00084
PlaintiffBayer AG
CourtMissouri Eastern
JudgeJohn A. Ross
FiledJanuary 25, 2023
ClosedDecember 18, 2024
Duration693 days
OutcomeJudgment on the merits for Plaintiff
Verdict causeInfringement Action
BasisJudgment on the merits for Plaintiff
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Missouri Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Judgment on the merits for Plaintiff in 693 days

693 days from filing to judgment — consistent with contested patent enforcement timelines in the Eastern District of Missouri

Case timeline: Complaint filed JAN 25 2023, JAN–FEB — 693 days total Horizontal timeline showing the three key events in Bayer AG v Michael J. Hodel from filing to resolution. Source: PACER, Missouri Eastern District Court. JAN 25 2023 Complaint filed Pre-trial proceedings DEC 18 2024 Judgment on the merits for Plaintiff 693 DAYS TOTAL
Court ruling

Summary judgment for Bayer & Monsanto: what the ruling means for both parties

Legal mechanism

Summary judgment: liability decided on undisputed facts

Summary judgment is granted when there is no genuine dispute of material fact and the moving party is entitled to judgment as a matter of law. Here, the court found the record sufficient to establish both patent infringement and TSA breach without trial. This typically signals that plaintiffs presented strong documentary evidence — seed sampling results, purchase records, or TSA acknowledgments — that defendant could not meaningfully contest.

No trial required
Patent holder outcome

Full relief: $603,965 damages and permanent injunction secured

Bayer and Monsanto obtained every category of relief sought: liquidated damages calculated across three TSA-covered seasons (2020–2022) and a permanent injunction that comprehensively bars Hodel from any future unauthorized use, saving, or transfer of patented biotech seed. The injunction also specifically targets unapproved dicamba applications to Xtend crops — extending beyond patent infringement into herbicide stewardship compliance.

Full injunctive + damages relief
Defendant outcome

Personal liability for three seasons of seed saving

As an individual defendant, Hodel faces direct personal liability for the full $603,965 judgment and is bound by the permanent injunction. The dual theory of liability — patent infringement and contract breach — is significant: even if patent claims were disputed, the TSA breach provided an independent damages pathway. The injunction’s scope effectively bars Hodel from growing Xtend soybeans under any commercial arrangement going forward without express written consent.

Personal monetary + injunctive liability
Commercial implications

Reinforces Bayer/Monsanto’s seed patent enforcement programme

This outcome is consistent with Monsanto’s longstanding enforcement strategy against seed saving, which typically relies on TSA liquidated damages clauses alongside patent claims to maximise recovery and minimise litigation risk. Summary judgment — rather than settlement — creates a public precedent demonstrating willingness to litigate to judgment. Growers using Xtend or other licensed biotech soybean varieties should treat TSA terms as legally binding and commercially enforceable obligations.

TSA enforcement precedent
Legal analysis based on PACER docket records for case 4:23-cv-00084 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffBayer AGCompanyAgricultural biotech — holders of US7838729B2 and US9944945B2 covering Xtend soybean technologySearch in Eureka ↗
Co-PlaintiffMonsanto Technology, LLCCompanySearch in Eureka ↗
DefendantMichael J. HodelIndividualIndividual Missouri farmer alleged to have saved and planted patented biotech soybean seed across three growing seasonsSearch in Eureka ↗
Plaintiff counselAnthony F. BlumAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselDaniel C. CoxAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselJeffrey A. MassonAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselMatthew S. BoberAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff law firmThompson Coburn LLP (St Louis)Law FirmRepresenting Bayer AGSearch in Eureka ↗
Defendant counselWendell L. Hoskins , IIAttorneyCounsel for Michael J. HodelSearch in Eureka ↗
Defendant law firmHoskins Law OfficeLaw FirmRepresenting Michael J. HodelSearch in Eureka ↗
Presiding judgeJudge John A. RossJudgeMissouri Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“IT IS HEREBY ORDERED, ADJUDGED and DECREED that summary judgment is entered in favor of Plaintiffs Bayer CropScience LP and Monsanto Technology LLC and against Defendant Michael Hodel. Defendant is liable for infringing Plaintiffs’ ‘945 and ‘729 patents and for breaching the parties’ Technology Stewardship Agreements for 2020, 2021, and 2022. Judgment is entered for Plaintiffs and against Defendant in the amount of $603,965 in liquidated damages, and Defendant is permanently enjoined from (1) making, using, saving, planting, selling, offering to sell, importing, or otherwise transferring any soybean or other seed containing Plaintiffs’ patented biotechnologies without express written permission and (2) applying unapproved formulations of dicamba-based herbicides to Xtend crops.”
Source: PACER Docket, Case 4:23-cv-00084, Missouri Eastern District Court

The verdict’s explicit enumeration of both patent infringement (the ‘945 and ‘729 patents) and TSA breach across three specific seasons reflects a deliberate dual-theory pleading strategy. By grounding liability in contract as well as patent law, plaintiffs ensured that even partial patent invalidity arguments could not defeat the damages claim. The liquidated damages figure of $603,965 — rather than a jury-assessed amount — suggests the TSA clauses contained pre-agreed per-season or per-acre penalty provisions that the court applied directly. The permanent injunction’s reach into dicamba application practices goes beyond typical patent remedies, suggesting the court accepted plaintiffs’ argument that herbicide stewardship obligations are independently enforceable.

PACER case 4:23-cv-00084 · Public docket record Explore in Eureka ↗
Patent at issue

US7838729B2 & US9944945B2 — Xtend soybean biotech platform patents

Publication No.US7838729B2
Application No.US11/758659
Patent details
ProductSoybean event MON89788 and methods for detecting the transgenic event in plant material
Cited in actionJanuary 25, 2023

Publication No.US9944945B2
Application No.US14/539923
Patent details
ProductChloroplast transit peptides enabling efficient targeting of DMO enzyme for dicamba tolerance in Xtend crops
Cited in actionJanuary 25, 2023

US7838729B2 (application no. 11/758,659) covers soybean event MON89788 — the transgenic insertion event underlying Roundup Ready 2 Yield soybeans — and detection methods used to confirm its presence in plant material. US9944945B2 (application no. 14/539,923) protects chloroplast transit peptide sequences enabling efficient targeting of the dicamba monooxygenase (DMO) enzyme, a core mechanism in Monsanto’s Xtend crop system conferring tolerance to dicamba-based herbicides. Together, these patents underpin two of the most commercially significant biotech soybean platforms in North American agriculture.

The commercial significance of these patents is substantial: Xtend soybeans represent one of the dominant trait platforms in US soybean production, with multi-million acre annual plantings. Enforcement of these patents alongside TSAs creates a layered IP protection model that makes unauthorised seed saving legally and commercially untenable. Competitors developing alternative dicamba-tolerance or herbicide-resistance platforms should monitor claim scope of the ‘945 patent closely, particularly the transit peptide claims, as they define a broad enabling mechanism rather than a single product configuration.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US9944945B2 and US7838729B2?

Any organisation developing transgenic soybean events, chloroplast-targeted enzyme delivery systems, or dicamba-tolerance traits should treat these patents as high-priority FTO targets. The ‘945 patent’s claims on chloroplast transit peptides for DMO targeting have broad applicability across herbicide-tolerance engineering, not solely Xtend soybeans. Similarly, ‘729’s event detection claims are relevant for any seed testing, trait stacking, or QC platform that screens for MON89788 presence in commercial seed lots.

PatSnap Eureka’s FTO Search Agent can map your own chloroplast targeting sequences, herbicide-tolerance constructs, or soybean event profiles against the claim landscape of both patents — identifying freedom-to-operate risk zones, relevant prior art that may affect claim validity, and analogous enforcement cases. R&D teams working on next-generation trait delivery should run this analysis before advancing candidates to field trials or licensing negotiations.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7838729B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar biotech seed patent enforcement cases in U.S. district courts

These cases involve biotech soybean and herbicide-tolerance patent enforcement actions in U.S. district courts, with comparable TSA breach and seed saving fact patterns to this Missouri Eastern District matter.

🔍
Access 40+ similar cases in PatSnap Eureka
Bayer AG patent enforcement history, Missouri Eastern case history, Bayer AG’s full IP portfolio, and comparable case analysis
Monsanto seed saving casesXtend soybean IP disputesTSA breach + patent infringementDicamba patent litigation
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the agricultural biotech IP landscape

This judgment reinforces the legal architecture protecting licensed biotech seed — and the personal exposure individual growers face when TSA terms are breached.

TSA liquidated damages clauses are litigation-ready enforcement tools

Bayer and Monsanto pursued dual theories — patent infringement and TSA breach — enabling a summary judgment award without needing to prove all elements of infringement at trial. Companies licensing biotech traits should audit whether their own stewardship agreements contain enforceable liquidated damages provisions calibrated to multi-season violations.

Summary judgment signals strong evidentiary position before filing

Securing summary judgment in a patent enforcement case is uncommon unless plaintiffs enter litigation with a robust evidence package. Seed sampling, purchase histories, and signed TSA acknowledgments typically form this foundation. Enforcement programmes built on systematic pre-litigation investigation are more likely to achieve this outcome than reactive filing.

🔒
Full strategic analysis in PatSnap Eureka
Unlock full strategic analysis of agricultural biotech patent enforcement at district court level, including TSA clause risk benchmarking and grower liability exposure mapping.
Injunction scope analysisTSA clause benchmarkingEnforcement programme risk map
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Bayer v Michael — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Track biotech seed patent enforcement and FTO risk in real time

PatSnap Eureka monitors enforcement actions across Monsanto and Bayer’s agricultural biotech patent portfolio. Run FTO searches against Xtend soybean patents and receive alerts when new seed technology infringement cases are filed.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.